As Head of the Cardiovascular and Metabolic Therapeutic Area Unit, Jamie Dananberg leads strategy development and execution for all product development for cardiovascular-, metabolic-, and respiratory-related diseases. Before joining Unity, Dananberg served as the Head of Therapeutic Area Leads group at Takeda Pharmaceuticals, developing cross-divisional strategies for Takeda’s development assets. Prior to his role at Takeda, Dr. Dananberg served as Vice President of Translational Medicine and Tailored Therapeutics at Eli Lilly and Company. A trained endocrinologist, Dananberg received his Doctor of Medicine and Bachelor of Science degrees from Tufts University in Boston.
2020 FALL CAMPAIGN is happening NOW
Please join us in supporting our students during this critical time with a one-time gift or pledge. Donate now